Results

Total Results: over 10,000 records

Showing results for "death".

  1. healthcare411.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/combined/c1_combo_prioritizationworksheet.xlsx
    July 01, 2016 - Trauma-Vaginal Delivery With Instrument   PSI 19 Obstetric Trauma-Vaginal Delivery Without Instrument   Death … PSI 02 Death in Low-Mortality DRGs   PSI 04 Death Among Surgical Inpatients   Sentinel Events (Adults
  2. talkingquality.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/combined/c1_combo_prioritizationworksheet.xlsx
    July 01, 2016 - Trauma-Vaginal Delivery With Instrument   PSI 19 Obstetric Trauma-Vaginal Delivery Without Instrument   Death … PSI 02 Death in Low-Mortality DRGs   PSI 04 Death Among Surgical Inpatients   Sentinel Events (Adults
  3. ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/combined/c1_combo_prioritizationworksheet.xlsx
    July 01, 2016 - Trauma-Vaginal Delivery With Instrument   PSI 19 Obstetric Trauma-Vaginal Delivery Without Instrument   Death … PSI 02 Death in Low-Mortality DRGs   PSI 04 Death Among Surgical Inpatients   Sentinel Events (Adults
  4. References (pdf file)

    www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
    August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in youths. Am J Psychiatry. 2009;166(9):992-1001.
  5. www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
    August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in youths. Am J Psychiatry. 2009;166(9):992-1001.
  6. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
    August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in youths. Am J Psychiatry. 2009;166(9):992-1001.
  7. References (pdf file)

    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
    August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in youths. Am J Psychiatry. 2009;166(9):992-1001.
  8. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
    August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in youths. Am J Psychiatry. 2009;166(9):992-1001.
  9. References (pdf file)

    www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
    August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in youths. Am J Psychiatry. 2009;166(9):992-1001.
  10. www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
    August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in youths. Am J Psychiatry. 2009;166(9):992-1001.
  11. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
    August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in youths. Am J Psychiatry. 2009;166(9):992-1001.
  12. References (pdf file)

    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
    August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in youths. Am J Psychiatry. 2009;166(9):992-1001.
  13. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
    August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in youths. Am J Psychiatry. 2009;166(9):992-1001.
  14. References (pdf file)

    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
    August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in youths. Am J Psychiatry. 2009;166(9):992-1001.
  15. References (pdf file)

    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
    August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in youths. Am J Psychiatry. 2009;166(9):992-1001.
  16. References (pdf file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
    August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in youths. Am J Psychiatry. 2009;166(9):992-1001.
  17. ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
    August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in youths. Am J Psychiatry. 2009;166(9):992-1001.
  18. nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Diseases_and_Conditions/Cardiovascular_Disease
    Home National View Diseases & Conditions Cardiovascular Disease Trend Summary Trend Data Back to National Cardiovascular Disease Trend Bar Graphs National Cardiovascular Disease Quality Measures Trend Over Time Trending information is available for NHQDR quality measures with at least four years o…
  19. effectivehealthcare.ahrq.gov/decision-aids/lung-cancer-screening/static/lung-cancer-screening-clin-summary.pdf
    March 01, 2016 - The median age at death was 72 years, and the number of deaths was 47 per 100,000 people.
  20. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/lung-cancer-screening-clin-summary.pdf
    March 01, 2016 - The median age at death was 72 years, and the number of deaths was 47 per 100,000 people.